ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2670

Premature Delivery in Patients with Systemic Lupus Erythematosus

Valeria Arturi, Pierina Sansinanea, Mariana Alejandra Pera, Adrian Pablo Salas, Josefina Marcos, Ana Carolina Costi, Claudia Elizabeth Pena and Mercedes Argentina García, Rheumatology Unit, HIGA San Martín La Plata, La Plata, Argentina

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: pregnancy and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose: Premature delivery (PD) is one of the most important difficultiess in perinatology. An incidence on developing countries of around 19% and 5-7% in developed nations is estimated. In Systemic Lupus Eritematosus (SLE) preterm delivery and stillbirth are still concerns, particularly in relation to pregnancies in patients with renal involvement, the presence of antiphospholipid antibodies (a-PL) or anti Phospholipidic Syndrome (APS). The aim of this study was to evaluate the prevalence of PD in patients with SLE and analyze the relationship between different factors related to the disease with fetal outcomes and neonatal mortality. 

Methods: Patients with SLE (1997 ACR criteria) with ≥ 1 pregnancy between 1987-2011 were analyzed. Premature delivery was defined as live birth before 37 weeks of gestation.  We compared the outcomes among PD pregnancies versus term pregnancies. The statistical analysis was performed with Chi-square test or test of Student as appropriate. 

Results: 166 pregnancies were recorded in 124 SLE patients. In 132/166 (79.5%) pregnancies were live birth. 46/132 (34.8%) were PD. Main causes of PD were: premature rupture of fetal membranes (21.7%), gestosis (19.6%) and placental insufficiency with intrauterine growth restriction (13%). Eight preterm newborn (17.4%) died in the neonatal period, 4 of them were part of the seven cases of extreme preterm birth (< 32 weeks of gestation). 

 

Preterm  46       

Term  98

p

OR

CI

APS

51%

32.65%

0.65

2.063

0.94-4.49

Previous nephropathy

32.6%

30.6%

1.000

1.063

0.46-2.39

Infections

24%

18.3%

0.505

1.39

0.54-3.52

Proteinuria

43.75%

10.2%

0.002

3.85

1.42-10.51

a- PL

77%

52.6%

0.006

3.06

1.27-7.49

Hydroxychloroquine

37%

40%

0.855

0.887

0.40-1.93

Pre-eclampsia

19.6%

11.2%

0.201

1.92

0.66-5.54

Cesarean delivery

58.7%

47%

0.212

1.61

0.74-3.48

Low birth weight

82.6%

10%

<0.0001

41.8

13.9-132

Neonatal Death

17.4%

4%

0.019

4.94

1.24-20.9

Conclusion: 34.8% of the 132 live newborns from mothers with SLE were preterm deliveries. Proteinuria during the course of the pregnancy and anti-phospholipid antibodies were significantly associated with PD. Patients with PD had increased the risk of having a newborn with low birth weight as well as increased mortality in the neonatal period, especially when the delivery occurred before 32 weeks of gestation.


Disclosure:

V. Arturi,
None;

P. Sansinanea,
None;

M. A. Pera,
None;

A. P. Salas,
None;

J. Marcos,
None;

A. C. Costi,
None;

C. E. Pena,
None;

M. A. García,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/premature-delivery-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology